352 related articles for article (PubMed ID: 29361915)
21. Syringomyelia-like syndrome in neuromyelitis optica spectrum disorder complicated with Sjogren's syndrome: a case report.
Li X; Lu Z; Wang Y
BMC Neurol; 2018 Oct; 18(1):168. PubMed ID: 30301458
[TBL] [Abstract][Full Text] [Related]
22. Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.
Kitley J; Waters P; Woodhall M; Leite MI; Murchison A; George J; Küker W; Chandratre S; Vincent A; Palace J
JAMA Neurol; 2014 Mar; 71(3):276-83. PubMed ID: 24425068
[TBL] [Abstract][Full Text] [Related]
23. Distinct genetic and infectious profiles in Japanese neuromyelitis optica patients according to anti-aquaporin 4 antibody status.
Yoshimura S; Isobe N; Matsushita T; Yonekawa T; Masaki K; Sato S; Kawano Y; Kira J;
J Neurol Neurosurg Psychiatry; 2013 Jan; 84(1):29-34. PubMed ID: 23038741
[TBL] [Abstract][Full Text] [Related]
24. Anti-aquaporin-4 antibody-seronegative NMO spectrum disorder with Baló's concentric lesions.
Masuda H; Mori M; Katayama K; Kikkawa Y; Kuwabara S
Intern Med; 2013; 52(13):1517-21. PubMed ID: 23812202
[TBL] [Abstract][Full Text] [Related]
25. Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study.
Pittock SJ; Lennon VA; McKeon A; Mandrekar J; Weinshenker BG; Lucchinetti CF; O'Toole O; Wingerchuk DM
Lancet Neurol; 2013 Jun; 12(6):554-62. PubMed ID: 23623397
[TBL] [Abstract][Full Text] [Related]
26. Nivolumab-induced autoimmune diabetes mellitus presenting as diabetic ketoacidosis in a patient with metastatic lung cancer.
Godwin JL; Jaggi S; Sirisena I; Sharda P; Rao AD; Mehra R; Veloski C
J Immunother Cancer; 2017; 5():40. PubMed ID: 28515940
[TBL] [Abstract][Full Text] [Related]
27. Clinical Features of Patients with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders.
Chen H; Liu SM; Zhang XX; Liu YO; Li SZ; Liu Z; Dong HQ
Chin Med J (Engl); 2016 Sep; 129(17):2079-84. PubMed ID: 27569235
[TBL] [Abstract][Full Text] [Related]
28. Paraneoplastic Neuromyelitis Optica Spectrum Disorder: A single center cohort description with two cases of histological validation.
Beauchemin P; Iorio R; Traboulsee AL; Field T; Tinker AV; Carruthers RL
Mult Scler Relat Disord; 2018 Feb; 20():37-42. PubMed ID: 29291482
[TBL] [Abstract][Full Text] [Related]
29. Presence of anti-Ro/SSA antibody may be associated with anti-aquaporin-4 antibody positivity in neuromyelitis optica spectrum disorder.
Park JH; Hwang J; Min JH; Kim BJ; Kang ES; Lee KH
J Neurol Sci; 2015 Jan; 348(1-2):132-5. PubMed ID: 25500159
[TBL] [Abstract][Full Text] [Related]
30. Utility of aquaporin-4 antibody assay in patients with neuromyelitis optica spectrum disorders.
Kim SM; Waters P; Woodhall M; Kim JY; Kim JE; Yang JW; Kim JS; Sung JJ; Park KS; Lee KW
Mult Scler; 2013 Jul; 19(8):1060-7. PubMed ID: 23329699
[TBL] [Abstract][Full Text] [Related]
31. Contribution of spinal cord biopsy to diagnosis of aquaporin-4 antibody positive neuromyelitis optica spectrum disorder.
Ringelstein M; Metz I; Ruprecht K; Koch A; Rappold J; Ingwersen J; Mathys C; Jarius S; Brück W; Hartung HP; Paul F; Aktas O;
Mult Scler; 2014 Jun; 20(7):882-8. PubMed ID: 24192218
[TBL] [Abstract][Full Text] [Related]
32. Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders.
Flanagan EP; Weinshenker BG; Krecke KN; Lennon VA; Lucchinetti CF; McKeon A; Wingerchuk DM; Shuster EA; Jiao Y; Horta ES; Pittock SJ
JAMA Neurol; 2015 Jan; 72(1):81-7. PubMed ID: 25384099
[TBL] [Abstract][Full Text] [Related]
33. Flaccid paralysis in neuromyelitis optica: An atypical presentation with possible involvement of the peripheral nervous system.
Grüter T; Ayzenberg I; Gahlen A; Kneiphof J; Gold R; Kleiter I
Mult Scler Relat Disord; 2018 Oct; 25():83-86. PubMed ID: 30056360
[TBL] [Abstract][Full Text] [Related]
34. Radiculopathy in neuromyelitis optica. How does anti-AQP4 Ab involve PNS?
Kim S; Park J; Kwon BS; Park JW; Lee HJ; Choi JH; Nam K
Mult Scler Relat Disord; 2017 Nov; 18():77-81. PubMed ID: 29141825
[TBL] [Abstract][Full Text] [Related]
35. A case of anti-AQP4 antibody-positive neuromyelitis optica spectrum disorder with MRI-proven lesions in lumbar nerve roots.
Toru S; Soejima I; Katayama Y; Saito K; Yokote H
Mult Scler Relat Disord; 2020 Nov; 46():102557. PubMed ID: 33296967
[TBL] [Abstract][Full Text] [Related]
36. Neuromyelitis Optica (Devic's Syndrome): an Appraisal.
Crout TM; Parks LP; Majithia V
Curr Rheumatol Rep; 2016 Aug; 18(8):54. PubMed ID: 27402111
[TBL] [Abstract][Full Text] [Related]
37. Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype.
Pröbstel AK; Rudolf G; Dornmair K; Collongues N; Chanson JB; Sanderson NS; Lindberg RL; Kappos L; de Seze J; Derfuss T
J Neuroinflammation; 2015 Mar; 12():46. PubMed ID: 25889963
[TBL] [Abstract][Full Text] [Related]
38. Epstein-Barr virus infection in a woman with aquaporin-4 seropositive neuromyelitis optica.
Naresh K; Miraclin TA; Prabhakar AT; Mathew V; Sivadasan A; Moorthy M; Prakash JAJ; Mathews DA; Benjamin RN
J Neuroimmunol; 2021 Jul; 356():577581. PubMed ID: 33940232
[TBL] [Abstract][Full Text] [Related]
39. Serum anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder presenting as acute eosinophilic encephalomyelitis.
Muroishi T; Sakai K; Yanase D; Ikeda Y; Machiya T; Kato-Motozaki Y; Samuraki M; Yamada M
J Clin Neurosci; 2018 Feb; 48():93-94. PubMed ID: 29137920
[TBL] [Abstract][Full Text] [Related]
40. Neuromyelitis optica associated with the use of Atezolizumab in a patient with advanced lung adenocarcinoma.
Pedrero Prieto M; Gorriz Romero D; Gómez Roch E; Pérez Miralles FC; Casanova Estruch B
Neurol Sci; 2024 May; 45(5):2199-2202. PubMed ID: 38091210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
